Chemotherapy, immunosuppression, and anesthesia

Ben Chortkoff, David Stenehjem

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.

Original languageEnglish (US)
Title of host publicationPharmacology and Physiology for Anesthesia
Subtitle of host publicationFoundations and Clinical Application
PublisherElsevier
Pages753-768
Number of pages16
ISBN (Electronic)9780323481106
ISBN (Print)9780323776981
DOIs
StatePublished - Jan 1 2018

Keywords

  • Angiogenesis
  • Cardiotoxicity
  • Immunotherapy
  • Malignancy
  • Metastasis
  • Monoclonal antibodies
  • Oxygen free radicals
  • Pulmonary fibrosis

Fingerprint Dive into the research topics of 'Chemotherapy, immunosuppression, and anesthesia'. Together they form a unique fingerprint.

  • Cite this

    Chortkoff, B., & Stenehjem, D. (2018). Chemotherapy, immunosuppression, and anesthesia. In Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application (pp. 753-768). Elsevier. https://doi.org/10.1016/B978-0-323-48110-6.00038-7